On October 25, Shenzhen Dayuan Chenguang Technology Co., Ltd. (“Dayuan Chenguang” for short) announced the completion of an angel round of financing of nearly 10 million yuan. This round of financing was led by Yanghe Capital, followed by the luminous giant Yahuilong (stock code: 688575). It is reported that this round of funds will be used to improve product layout, increase market investment, and build new plants and teams.
Founded in 2015, Dayuan Chenguang focuses on comprehensive solutions for diagnostic research and molecular biology that meet the needs of future advanced laboratories. The company was founded by university professors, returned technical experts and senior experts who have been deeply involved in the biotechnology market for decades, and has accumulated rich industry experience in mechanical automation, biochemical reagents and high-value consumables.
After years of technology research and development and accumulation, the company has launched China’s first focused ultrasonic sample processing system, the world’s exclusive flow vacuum degassing system, laboratory consumables and protein biological products and many other leading technology products. Provide more advanced scientific research and clinical overall laboratory solutions.
media coverage
China Investment Network Yiou Investment Community
Related events
- Dayuan Chenguang received nearly 10 million yuan in angel round financing2022-10-25
- Huapu Instruments received 100 million yuan angel round financing2022-08-29
- SCRM system micro group received nearly 10 million yuan of strategic financing2022-08-25
- Zebrafish Digital Intelligence has completed nearly 10 million yuan in angel round financing2022-03-23
- Insight Data received nearly 10 million yuan in angel round financing2018-02-05
This article is reprinted from: https://readhub.cn/topic/8kovwfsAmpo
This site is for inclusion only, and the copyright belongs to the original author.